{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:56:27Z","timestamp":1791294987843,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.encep.2014.12.002","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T18:03:12Z","timestamp":1421344992000},"page":"84-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Histoire des traitements antipsychotiques \u00e0 action prolong\u00e9e dans la schizophr\u00e9nie"],"prefix":"10.1016","volume":"41","author":[{"given":"M.-A.","family":"Crocq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2014.12.002_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0013-7006(13)70121-0","article-title":"Recommandations formalis\u00e9es d\u2019experts de l\u2019AFPBN\u00a0: prescription des neuroleptiques et antipsychotiques d\u2019action prolong\u00e9e","volume":"39","author":"Samalin","year":"2014","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2014.12.002_bib0010","series-title":"Antipsychotic long-acting injections","first-page":"V","year":"2011"},{"key":"10.1016\/j.encep.2014.12.002_bib0015","series-title":"Trait\u00e9 des maladies mentales","first-page":"566","author":"Morel","year":"1860"},{"key":"10.1016\/j.encep.2014.12.002_bib0020","series-title":"Psychiatrie. Ein Lehrbuch f\u00fcr Studierende und \u00c4rzte. Sechste Auflage","author":"Kraepelin","year":"1899"},{"key":"10.1016\/j.encep.2014.12.002_bib0025","series-title":"Dementia Praecox oder Gruppe der Schizophrenien","author":"Bleuler","year":"1911"},{"key":"10.1016\/j.encep.2014.12.002_bib0030","series-title":"Therapie der Geisteskrankheiten f\u00fcr praktische und Irren\u00e4rzte","author":"Becker","year":"1911"},{"key":"10.1016\/j.encep.2014.12.002_bib0035","series-title":"Sigmund Freud\u2013Eugen Bleuler\u2013Briefwechsel 1904\u20131937 (Correspondance entre S.\u00a0Freud et E.\u00a0Bleuler)","first-page":"199","year":"2012"},{"key":"10.1016\/j.encep.2014.12.002_bib0040","series-title":"Pharmacy through the ages","article-title":"Pharmacology in the nineteenth century","author":"Pogliano","year":"1989"},{"issue":"6","key":"10.1016\/j.encep.2014.12.002_bib0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0010-440X(99)90082-2","article-title":"A history of antipsychotic drug development","volume":"40","author":"Shen","year":"1999","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0050","first-page":"503","article-title":"Trente-huit cas de psychoses trait\u00e9s par la cure prolong\u00e9e et continue de 4560RP","volume":"50","author":"Delay","year":"1952","journal-title":"C R Congr Med Alien Neurol Francaise"},{"key":"10.1016\/j.encep.2014.12.002_bib0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0893-133X(93)00017-G","article-title":"Psychopharmacology: finding one's way","volume":"12","author":"Elkes","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.encep.2014.12.002_bib0060","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/bmj.2.5197.522","article-title":"Chlorpromazine and allied phenothiazine derivatives","volume":"2","author":"Rees","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.encep.2014.12.002_bib0065","series-title":"Diabetes. The biography","author":"Tattersall","year":"2009"},{"key":"10.1016\/j.encep.2014.12.002_bib0070","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/bmj.2.4847.1180","article-title":"Centenary of hypodermic injection","volume":"28","author":"Mogey","year":"1953","journal-title":"Br Med J"},{"key":"10.1016\/j.encep.2014.12.002_bib0075","doi-asserted-by":"crossref","first-page":"s7","DOI":"10.1192\/bjp.195.52.s7","article-title":"Historical perspective on antipsychotics long-acting injections","volume":"195","author":"Johnson","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0080","first-page":"1610","article-title":"Traitement antipsychotique au moyen des pr\u00e9parations injectables \u00e0 lib\u00e9ration prolong\u00e9es actuelles","volume":"30","author":"Yastrebov","year":"2013","journal-title":"Russian Med J"},{"key":"10.1016\/j.encep.2014.12.002_bib0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/bj0310475","article-title":"The prolonged treatment of castrated and ovariectomized rats with testosterone propionate","volume":"31","author":"Korenchevsky","year":"1937","journal-title":"Biochem J"},{"key":"10.1016\/j.encep.2014.12.002_bib0090","first-page":"392","article-title":"Excretion of 17-ketosteroids following injections of testosterone enanthate","volume":"9","author":"Schneider","year":"1954","journal-title":"Arztl Wochensch"},{"key":"10.1016\/j.encep.2014.12.002_bib0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0140-6736(61)90636-5","article-title":"Depot-methylprednisolone for subconjunctival and retrobulbar injections","volume":"2","author":"Gebertt","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2014.12.002_bib0100","series-title":"Kompendium der psychiatrischen Pharmakotherapie","author":"Benkert","year":"2011"},{"issue":"Suppl. 2","key":"10.1016\/j.encep.2014.12.002_bib0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2125.1976.tb03736.x","article-title":"Assessment of depot neuroleptics","volume":"3","author":"Daniel","year":"1976","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.encep.2014.12.002_bib0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.1.5854.633","article-title":"Out-patient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial","volume":"1","author":"Hirsch","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.encep.2014.12.002_bib0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/bmj.2.5860.244-c","article-title":"Outpatient maintenance of chronic schizophrenics with long-acting fluphenazine","volume":"2","author":"Daniel","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.encep.2014.12.002_bib0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/bmj.3.5775.599","article-title":"Trial of maintenance therapy in schizophrenia","volume":"3","author":"Leff","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.encep.2014.12.002_bib0125","series-title":"A historical dictionary of psychiatry","author":"Shorter","year":"2005"},{"key":"10.1016\/j.encep.2014.12.002_bib0130","first-page":"35","article-title":"Ein eigent\u00fcmliches Syndrom im oralen Bereich bei Megaphenapplikation","volume":"28","author":"Sch\u00f6necker","year":"1957","journal-title":"Nervenarzt"},{"key":"10.1016\/j.encep.2014.12.002_bib0135","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1192\/bjp.115.523.679","article-title":"Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication","volume":"115","author":"Prien","year":"1969","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0140","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/archpsyc.1979.01780120013001","article-title":"Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride","volume":"36","author":"Hogarty","year":"1979","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0145","series-title":"Reflections on twentieth-century psychopharmacology","article-title":"The history of psychotropic drugs in the United Kingdom","author":"Wheatley","year":"2004"},{"issue":"3","key":"10.1016\/j.encep.2014.12.002_bib0150","first-page":"157","article-title":"Prescribing patterns of neuroactive drugs in 98 schizophrenic patients","volume":"26","author":"Heresco-Levy","year":"1989","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"7","key":"10.1016\/j.encep.2014.12.002_bib0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/14737175.2013.811984","article-title":"New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia","volume":"13","author":"Citrome","year":"2013","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.encep.2014.12.002_bib0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3371\/CSRP.GOAG.043013","article-title":"Long-acting injectable aripiprazole: how might it fit in our tool box?","volume":"7","author":"Gopalakrishna","year":"2013","journal-title":"Clin Schizophr Relat Psychoses"},{"issue":"1","key":"10.1016\/j.encep.2014.12.002_bib0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.schres.2013.06.041","article-title":"Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose study","volume":"150","author":"Mallikaarjun","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2014.12.002_bib0170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: an instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophr Bull"},{"issue":"7","key":"10.1016\/j.encep.2014.12.002_bib0175","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","article-title":"Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials","volume":"160","author":"Leucht","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2014.12.002_bib0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1176\/appi.ajp.2009.07081221","article-title":"Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia","volume":"167","author":"Kane","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2014.12.002_bib0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/appi.ajp.2009.09111676","article-title":"The use of depot medications in the treatment of schizophrenia","volume":"167","author":"Davis","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0190","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jclinepi.2013.01.012","article-title":"Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry","volume":"66","author":"Kane","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.encep.2014.12.002_bib0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2003.11.001","article-title":"Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia","volume":"70","author":"Eerdekens","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2014.12.002_bib0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2006-946703","article-title":"A comparative efficacy and safety study of long-acting risperidone injection and risperidone oral tablets among hospitalized patients: 12-week randomized, single-blind study","volume":"39","author":"Bai","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0205","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2014.12.002_bib0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2003.11.001","article-title":"Pharmacokinetics and tolerability of long-acting injectable risperidone in schizophrenia","volume":"70","author":"Eerdekens","year":"2004","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.encep.2014.12.002_bib0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S1461145705005225","article-title":"Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial","volume":"8","author":"Lasser","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2014.12.002_bib0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/YIC.0b013e3280119ddb","article-title":"Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone","volume":"22","author":"Schmauss","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2014.12.002_bib0225","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1176\/appi.ajp.2013.12050674","article-title":"Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study","volume":"170","author":"Andreasen","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0230","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-244X-13-340","article-title":"Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness","volume":"13","author":"Llorca","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0235","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4088\/JCP.12r08167","article-title":"Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs","volume":"74","author":"Kirson","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0240","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4088\/JCP.13r08440","article-title":"Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies","volume":"74","author":"Kishimoto","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2014.12.002_bib0245","first-page":"1","article-title":"Hospitalization rates in patients switched from oral antipsychotics to aripiprazole once-monthly: final efficacy analysis","author":"Kane","year":"2014","journal-title":"J Med Econ"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700614002838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700614002838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T15:24:28Z","timestamp":1566228268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700614002838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0013700614002838"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2014.12.002","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histoire des traitements antipsychotiques \u00e0 action prolong\u00e9e dans la schizophr\u00e9nie","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 L\u2019Enc\u00e9phale, Paris. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}